Sectoral Asset Management’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-399,949
Closed -$7.6M 116
2021
Q4
$7.6M Buy
399,949
+5,000
+1% +$130K 1.14% 36
2021
Q3
$13.1M Sell
394,949
-20,000
-5% -$619K 1.09% 28
2021
Q2
$16.1M Sell
414,949
-98,700
-19% -$3.88M 1.3% 26
2021
Q1
$24.8M Buy
513,649
+307,100
+149% +$14.8M 1.88% 11
2020
Q4
$10.7M Buy
+206,549
New +$6.98M 0.76% 49
2017
Q4
Sell
-100,366
Closed -$1.19M 70
2017
Q3
$1.19M Buy
100,366
+19,100
+24% +$218K 0.15% 60
2017
Q2
$817K Sell
81,266
-56,234
-41% -$629K 0.09% 58
2017
Q1
$1.6M Buy
+137,500
New +$987K 0.19% 53
2016
Q2
Sell
-1,521,667
Closed -$13M 76
2016
Q1
$13M Hold
1,521,667
0.63% 42
2015
Q4
$18.2M Buy
1,521,667
+57,562
+4% +$727K 0.77% 35
2015
Q3
$14.8M Buy
1,464,105
+692,088
+90% +$10.3M 0.68% 38
2015
Q2
$12.8M Buy
772,017
+335,933
+77% +$5.32M 0.53% 48
2015
Q1
$6.75M Buy
+436,084
New +$6.6M 0.26% 55

Other funds holding TGTX

Sectoral Asset Management's TGTX Position: Q1 2022 in Review

Sectoral Asset Management sold out of TG Therapeutics (TGTX) in Q1 2022, closing a stake of 399,949 shares — an estimated $7.6M sold.

Sectoral Asset Management first reported a position in TGTX in Q1 2015 and held it in 13 quarters. The position peaked at $24.8M in Q1 2021. 181 funds tracked by Wall St. Rank hold TGTX as of Q1 2022.

  • Sectoral Asset Management reported no remaining TG Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Sectoral Asset Management sold 399,949 TG Therapeutics shares in Q1 2022, an estimated $7.6M.
  • Sectoral Asset Management first reported a position in TG Therapeutics in Q1 2015 and held it in 13 quarters.
  • Sectoral Asset Management's TG Therapeutics position peaked at $24.8M in Q1 2021.
  • 181 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2022.

Based on Sectoral Asset Management's 13F filing for Q1 2022, filed 10 May 2022.